Core Viewpoint - The Ministry of Industry and Information Technology (MIIT) aims to deepen the integration of technology and finance, focusing on fostering high-quality projects in key sectors such as biomanufacturing, artificial intelligence, digital technology, and low-altitude economy [1] Group 1: Project Development - MIIT will focus on identifying early-stage hard technology projects and connecting them with national innovation resources and financial support to promote the implementation of high-quality projects [1] - The initiative emphasizes the cultivation of quality projects in emerging fields, which is expected to enhance the overall innovation landscape [1] Group 2: Financing Support - MIIT plans to leverage mechanisms such as the "green channel" for financing through public offerings, mergers and acquisitions, and bond issuance to ensure funding for key areas and critical links [1] - The strategy aims to guide social capital towards providing sustainable funding through multiple channels [1] Group 3: Financial Tool Innovation - There will be a strategic collaboration with financial institutions to optimize the combination of financial tools, promoting the application of the "pilot insurance + R&D loan" model to boost market confidence among pilot project parties and investors [1] Group 4: Innovation Capability Evaluation - MIIT will promote the application of an enterprise innovation point system, facilitating collaboration with quality enterprise cultivation and technology achievement transformation [1] - The initiative aims to guide financial institutions in refining financial products and services to empower the innovative development of technology-based enterprises [1]

Group 1 - The core viewpoint of the news is the release of the "Policy Measures" by seven government departments to accelerate the construction of a technology finance system that supports high-level technological self-reliance and strength [1] - The "Policy Measures" propose 15 specific initiatives focusing on enhancing financial support for major technological tasks and technology-based small and medium-sized enterprises [1] - The establishment of a "National Venture Capital Guidance Fund" aims to promote the growth of technology-based enterprises and foster the development of strategic emerging industries, particularly future industries [1][2] Group 2 - The National Venture Capital Guidance Fund will focus on guiding financial capital to invest early, small, long-term, and in hard technology, targeting cutting-edge fields such as artificial intelligence, quantum technology, and hydrogen energy storage [2] - The "Policy Measures" emphasize the importance of structural monetary policy tools to support technological innovation, including expanding the scale of re-lending and optimizing support mechanisms for technology-based SMEs [2][3] - The measures also highlight the need to enhance capital market support for technology innovation enterprises by improving the mechanism for counter-cyclical adjustment of new stock issuance and prioritizing financing for enterprises that achieve breakthroughs in key core technologies [3]

创投行业再迎重磅利好。 5月14日，科技部等七部门联合发布《加快构建科技金融体制有力支撑高水平科技自立自强的若干政策 举措》（以下简称《政策举措》）。 《政策举措》聚焦服务于国家重大科技战略部署，着力构建同科技创新相适应的科技金融体制，加强对 国家重大科技任务和科技型中小企业的金融支持，重点围绕创业投资、货币信贷、资本市场、科技保险 支持科技创新，加强财政政策引导，健全科技金融统筹推进机制以及完善科技金融生态等七个方面内 容，凝练了15项科技金融政策举措。 在发挥创业投资支持科技创新生力军作用方面，《政策举措》提出，设立"国家创业投资引导基金"。发 挥国家创业投资引导基金支持科技创新的重要作用，将促进科技型企业成长作为重要方向，培育发展战 略性新兴产业特别是未来产业，推动重大科技成果向现实生产力转化，加快实现高水平科技自立自强， 培育发展新质生产力。 21世纪经济报道记者注意到，这只国家创业投资引导基金其实在两个月前就进行了"官宣"。3月6日，国 家发展改革委主任郑栅洁在全国两会经济主题记者会上透露，国家正在推动设立"航母级"的国家创业投 资引导基金。 "此次《政策举措》提出设立'国家创业投资引导基金'，意味 ...

作为新质生产力的代表，合成生物学、生物制造以及生物产业，近些年，受到来自政产学研用金各 方广泛关注和重点支持，多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家， 在产业发展中发挥着重要作用。 融行业智慧、共襄盛举 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办（同期举办 第七届CMC-China博览会 ）！ 扫码！锁定免费参会名额！ 话题将覆盖： 农业、食品与能源， 医美、医药、大健康 ， 合成生物技术、中试放大与商业化， 以 及 项目路演 等多个方面，诚邀莅临，共襄盛举！ 往期精彩： 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码！锁定免费参会名额！ 储震宇 芯宿科技 联合创始人&CSO 圆满落幕！下一站去哪？2023中国（苏州）合成生物学创新峰会成功 举办 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物，聚势苏州：2024中国合成生物学"科学家+企业家+投资 家"大会圆满召开！ 往期嘉宾 阵容 (按首 ...

作为新质生产力的代表，合成生物学、生物制造以及生物产业，近些年，受到来自政产学研用金各 方广泛关注和重点支持，多地政府将合成生物制造产业写进工作报告。 科学家、企业家和投资家， 在产业发展中发挥着重要作用。 聚产业力量、擘画未来 第三届SynBio Suzhou中国合成生物学"科学家+企业家+投资家"大会 将于2025年8月1-2日在 苏州 国际博览中心 举办（同期举办 第七届CMC-China博览会 ）！ 融行业智慧、共襄盛举 扫码！锁定免费参会名额！ 话题将覆盖： 农业、食品与能源， 医美、医药、大健康 ， 合成生物技术、中试放大与商业化， 以 及 项目路演 等多个方面，诚邀莅临，共襄盛举！ 往期精彩： 大会主办丨 Synbio深波 会议时间 | 2025年8月1-2日 会议地点 | 中国·苏州·国际博览中心B馆 扫码！锁定免费参会名额！ 圆满落幕！下一站去哪？2023中国（苏州）合成生物学创新峰会成功 举办 2023中国(苏州)合成生物学产业技术峰会圆满落幕 合成生物，聚势苏州：2024中国合成生物学"科学家+企业家+投资 家"大会圆满召开！ 往期嘉宾 阵容 (按首字母排序,排名不分先后，嘉宾单位或头衔 ...

Sales Performance - In the 2024-2025 operating year, the company achieved corn seed sales of over 30 million kilograms, with "Tie 391" and "Tie 391K" accounting for over 11 million kilograms [2] - The main promoted corn varieties in Northeast and Northwest regions are "Tie 391" and "Tie 391K," while "Fengle 520" leads the green high-resistance series in the Huang-Huai-Hai market [2][3] - The sales of "Fengle 520" reached over 4 million kilograms in the 2024-2025 operating year [3] Inventory and Production - As of the end of Q1 2025, inventory was 937 million RMB, a year-on-year increase of 264 million RMB from 673 million RMB in Q1 2024, primarily due to increased corn seed inventory [3] - The company expects to reduce the seed production area in 2025 based on market inventory assessments [3] Financial Strategy - The company plans to raise a total of no more than 1,088.6486 million RMB through a private placement, which will be used to supplement working capital and repay bank loans [3] - This fundraising is aimed at optimizing the asset-liability structure and enhancing financial strength for high-quality R&D and operational development [3] Agricultural and Chemical Business - In 2025, the company will increase R&D investment in the agricultural chemical sector, focusing on green and low-residue pesticides and bio-pesticides [4] - The strategy includes upgrading production lines and exploring new crop solutions to seek new economic growth points [4] Spice Business Development - The spice industry will focus on product differentiation and market strategies, aiming to solidify the market position of natural menthol and menthol oil [4] - The company plans to cultivate potential products like peppermint oil and develop 2-3 core products, while also preparing for market entry of new products [4]

Core Viewpoint - The company has shown significant improvement in its first-quarter performance for 2025, with a notable increase in revenue, despite a decline in net profit compared to the previous year [1][2]. Financial Performance - In 2024, the company achieved revenue of 2.178 billion, a year-on-year increase of 12.37%, but the net profit attributable to shareholders was 190 million, down 57.80% year-on-year [1]. - The fourth quarter of 2024 saw revenue of 639 million, up 11.29% year-on-year and 22.21% quarter-on-quarter, with a net profit of 20 million, down 84.80% year-on-year [1]. - For the first quarter of 2025, the company reported revenue of 687 million, a year-on-year increase of 37.20% and a quarter-on-quarter increase of 7.54%, with a net profit of 51 million, down 40.98% year-on-year but up 160.36% quarter-on-quarter [1]. Profitability Metrics - The gross margin for 2024 was 24.92%, a decrease of 15.60 percentage points year-on-year, while the net margin was 8.47%, down 14.57 percentage points year-on-year [1]. - In Q4 2024, the gross margin was 17.20%, down 21.47 percentage points year-on-year, and the net margin was 2.59%, down 19.57 percentage points year-on-year [1]. - For Q1 2025, the gross margin was 24.31%, down 9.27 percentage points year-on-year, and the net margin was 7.15%, down 10 percentage points year-on-year [1]. Market and Product Development - The company faces increased market competition, particularly with the price decline of key products like valine, which has pressured profits [2]. - Positive progress has been made in new product promotion, with breakthroughs in products such as 1,3-propanediol, succinic acid, tryptophan, and arginine, which are expected to open new market opportunities [2]. - The establishment of the "Biobased Polyester Textile Industry Alliance" aims to accelerate domestic material substitution and address core material industry challenges [2]. Investment Outlook - Forecasts for 2025 to 2027 predict revenues of 2.536 billion, 2.905 billion, and 3.285 billion, with year-on-year growth rates of 16.4%, 14.6%, and 13.1% respectively [3]. - Expected net profits for the same period are 266 million, 397 million, and 506 million, with growth rates of 40.2%, 49.3%, and 27.6% respectively [3]. - The company is rated as "Buy-A" considering the market conditions for valine and other amino acids [3].

Group 1 - The article highlights the growing attention and support for synthetic biology, biomanufacturing, and the bio-industry from various sectors including government, academia, and investment, with many local governments incorporating synthetic biological manufacturing into their work reports [1] - The upcoming third SynBio Suzhou conference will take place on August 1-2, 2025, at the Suzhou International Expo Center, covering topics such as agriculture, food, energy, medical aesthetics, pharmaceuticals, and health [3] - The seventh CMC-China Expo is expected to attract 20,000 attendees, featuring 450 exhibiting companies and 600 invited guests, with multiple forums and a dedicated synthetic biology exhibition area [16] Group 2 - The article lists notable past guests and speakers from various institutions and companies, indicating a diverse representation of expertise in the field of synthetic biology [4][7][9] - The event aims to gather scientists, entrepreneurs, and investors to collaborate and discuss the future of synthetic biology and its applications [2][3] - The article emphasizes the importance of industry collaboration and innovation in advancing synthetic biology and biomanufacturing [1][26]

Group 1 - The article highlights the growing attention and support for synthetic biology, biomanufacturing, and the bio-industry from various sectors including government, academia, and investment, with many local governments incorporating synthetic biological manufacturing into their work reports [1] - The upcoming third SynBio Suzhou conference will take place on August 1-2, 2025, at the Suzhou International Expo Center, covering topics such as agriculture, food, energy, medical aesthetics, pharmaceuticals, and health [3] - The seventh CMC-China Expo is expected to attract 20,000 attendees, featuring 450 exhibiting companies and 600 invited guests, with multiple forums and a dedicated synthetic biology exhibition area [16] Group 2 - The article lists notable past guests from various institutions and companies, indicating a diverse representation of expertise in the field of synthetic biology and biomanufacturing [4][7][9] - The conference aims to gather scientists, entrepreneurs, and investors to collaborate and discuss the future of synthetic biology, emphasizing the importance of industry collaboration [2][3] - The article encourages participation in the conference by offering free registration for attendees, highlighting the event's accessibility to a broader audience [13][14]

Core Viewpoint - The collaboration between Bio Island Laboratory and Wanhua Chemical aims to innovate in the field of bio-based materials, positioning both entities as leaders in the industry [1][2]. Group 1: Collaboration and Innovation - Bio Island Laboratory and Wanhua Chemical signed an agreement to establish the "Bio Island Laboratory-Wanhua Chemical Bio-Chemical Research and Manufacturing Innovation Consortium" [1]. - The partnership focuses on continuous innovation in bio-based materials and aims to lead the direction of industry development [1][2]. - The collaboration is part of a broader initiative to create a "government-industry-university-research-finance-application" ecosystem to accelerate the transformation of scientific achievements into productive forces [2]. Group 2: Industry Insights - The bio-manufacturing industry is projected to reach a value of approximately $30 trillion, making it a strategic area of competition among countries [2]. - Guangzhou's government is committed to supporting the transformation of scientific achievements and fostering innovation in the bio-economy, aiming to secure a strategic position in the future of this sector [2]. Group 3: Related Developments - The National Development and Reform Commission has included multiple projects related to bio-based materials and biofuels [5]. - Companies like Lianlong are leveraging synthetic biology to develop high-performance materials, indicating a trend towards innovation in polymer materials [5]. - A startup in synthetic biology has raised $6.7 million in seed funding to advance applications in protein fibers, showcasing the growing interest and investment in this field [5].